Clinical Trials Directory

Trials / Unknown

UnknownNCT04688242

Anal Dilatation Plus Probiotics Before Ileostomy Reduction for Low Anterior Resection Syndrome

A Randomized, Phase 2 Study of Anal Dilatation Plus Probiotics Before Ileostomy Reduction for Low Anterior Resection Syndrome After Sphincter-preserving Proctectomy

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
164 (estimated)
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is randomized, phase 2 trial in patients with rectal cancer undergoing sphincter-preserving proctectomy and temporary ileostomy, to explore the effects of anal dilatation plus probiotics administered per anus before ileostomy reduction in relieving postoperative bowel dysfunction known as low anterior resection syndrome (LARS).

Detailed description

Approximately 60-90% of patients undergoing sphincter-sparing proctectomy complain of postoperative bowel dysfunction including incontinence, frequency, clustering, and urgency, collectively known as low anterior resection syndrome (LARS). Literatures and our previous data have demonstrated that diverting ileostomy is an independent risk factor for major LARS. This is a randomized, phase 2 trial in patients with rectal cancer who underwent sphincter-preserving proctectomy and ileostomy. This study will explore the effects of anal dilatation plus probiotics administered per anus in relieving the symptoms of LARS.

Conditions

Interventions

TypeNameDescription
OTHERAnal dilatation per anusDigital anal dilatation through anastomosis, with concomitant administration of probiotics per anus
DRUGadministration of probiotics (Clostridium butyricum TO-A; Bacillus mesentericus TO-A; Streptococcus faecalisT-110) per anusDigital anal dilatation through anastomosis, with concomitant administration of probiotics per anus

Timeline

Start date
2021-02-20
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2020-12-29
Last updated
2022-12-06

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04688242. Inclusion in this directory is not an endorsement.